Jefferies Very Selective on Defense and Aerospace Stocks for 2017
While the run in defense and aerospace stocks was good for shareholders, many on Wall Street are starting to take a more cautious view on the sector in 2017.
While the run in defense and aerospace stocks was good for shareholders, many on Wall Street are starting to take a more cautious view on the sector in 2017.
These Jefferies picks make sense for investors as they all have solid upside potential and outstanding core business silos, and they all pay a dividend.
While there is no guarantee any of these software companies surprise to the upside, the stars appear to be aligning for all of them, and the odds based on past performance look good as…
With the first earnings starting to hit the tape last week, the windows for insiders at public companies are starting to slam shut. Volume was nothing compared to in the weeks leading up to…
As we suspected, it now appears that many top insiders at companies put off selling shares last year, and moved their sales into 2017, and there is a very good reason.
In a recent research report, Jefferies outstanding internet analyst Brian Fitzgerald highlighted 10 top themes for the internet for 2017, and some of them are directly related to Donald Trump becoming president.
With the dollar getting stronger almost daily, it makes sense for investors to buy stock in companies with the bulk of their profit coming from their U.S. businesses.
Chasing stocks in an overbought market is dangerous. With that in mind, overbought markets can go higher. These stocks hold the proverbial big risk, big reward handle.
Despite the Baird prowess in small and mid-cap coverage, many of their top picks in technology remain the mega-cap leaders, and with good reason.
The halcyon days of huge gains for the utility sector are over, but it always makes sense to keep a weighting of these stocks in a well-rounded portfolio.
These are five top new picks that the JPMorgan team likes this month. All make good sense for growth portfolios.
While nobody knows exactly what this year will bring, oil prices appear solidly over the $50 a barrel level, so a push to the $60 level is not out of the question in 2017.
Needless to say, the past two years have been rough on biotech. The question for investors is which of the stocks hold the best potential in 2017.
Many of the top firms we cover here at 24/7 Wall St. are already tweaking their high conviction stocks lists for 2017, and many are trying to take into account macro changes that could…
There is an investment vehicle that may offer investors a way to stay in equities, get paid solid dividends and have the potential for outperforming total return.
The volume of insider activity has started to dry up as we get closer to the fourth-quarter earnings reports, and as usual, it could stay low most of the month of January.
We saw a ton of insider selling last week, as insiders, hedge funds and other institutional accounts appear to have waited until 2017 to sell shares, with the notion that nominal tax rates soon…
These four banks may be just the kind of institutions that could benefit from a solid debt-trading scenario. Any increase in overall business could push earnings above current expectations.
A new Jefferies research report makes the case that five top biotech companies may be right in the cross-hairs of the biotech giants or perhaps large pharmaceutical companies.
A new Jefferies research report, while conceding that near-term fundamentals for many of the top companies in the restaurant arena are difficult, focuses on four top new money buys for 2017.